TherapeuticsMD, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
TherapeuticsMD, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • TherapeuticsMD, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $6.5M, a 10.1% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $6.5M -$731K -10.1% Jun 30, 2024 10-Q 2024-08-12
Q4 2023 $6.87M -$707K -9.33% Dec 31, 2023 10-Q 2024-08-12
Q3 2023 $7.06M -$694K -8.96% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $7.23M -$686K -8.67% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $7.41M -$669K -8.29% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $7.58M -$654K -7.94% Dec 31, 2022 10-K 2024-03-29
Q3 2022 $7.75M -$642K -7.65% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $7.91M -$924K -10.5% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $8.08M -$1.13M -12.3% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $8.23M -$1.33M -13.9% Dec 31, 2021 10-K 2023-04-07
Q3 2021 $8.39M -$1.58M -15.9% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $8.84M -$1.5M -14.5% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $9.21M -$552K -5.66% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $9.57M -$543K -5.37% Dec 31, 2020 10-K 2022-03-23
Q3 2020 $9.98M -$484K -4.63% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $10.3M +$7.02M +212% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 $9.76M +$6.22M +176% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $10.1M +$6.31M +166% Dec 31, 2019 10-K 2021-03-04
Q3 2019 $10.5M Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $3.32M Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $3.54M Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $3.8M Jan 1, 2019 10-Q 2019-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.